Back to BlackRock, Inc. BlackRock, Inc.

TNGXTNGX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Tango Therapeutics, Inc.

BlackRock, Inc. holds 12.4M shares of TNGX (Tango Therapeutics, Inc.), worth $388.8M as of 2026-Q2. The position was increased (+42.2% shares). TNGX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$388.8M

Current Shares

12.4M

Total Value Change

+$375.3M

Total Shares Change

+8.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12.4M
+42.2%
$388.8M0.0%$31.26
42
2026-Q1
Increased
8.7M
+2.4%
$183M0.0%$11.50
31
2025-Q4
Increased
8.5M
+51.3%
$75.7M0.0%$8.63
41
2025-Q3
Increased
5.6M
+3.4%
$47.4M0.0%$8.44
30
2025-Q2
Increased
5.5M
+35.5%
$28M0.0%$5.01
37
2025-Q1
Decreased
4M
-7.9%
$5.5M0.0%$1.47
0
2024-Q4
New
4.4M
-
$13.5M0.0%$3.10
39

Other major holders of TNGX: RTW INVESTMENTS, LP, FMR LLC, FARALLON CAPITAL MANAGEMENT, L.L.C., GOLDMAN SACHS GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used